Click for best price
Stem Cells Market Size, Share 2022
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
This report contains market size and forecasts of Stem Cells in Global, including the following market information:
Global top five companies in 2021 (%)
The global Stem Cells market was valued at 2832.7 million in 2021 and is projected to reach US$ 5673.4 million by 2028, at a CAGR of 10.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Storage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stem Cells Market Segment Percentages, by Type, 2021 (%)
- Stem Cell Storage
- Stem Cell Pharmaceutical and Treatment
Global Stem Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stem Cells Market Segment Percentages, by Application, 2021 (%)
- Blood Disease
- Cancer
- Autoimmune Disease
- Others
Global Stem Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stem Cells Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Stem Cells revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Stem Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- Medi-post
- JCR Pharmaceutical
- MolMed
- Pharmicell
- Anterogen
- Takeda (TiGenix)
- CBR
- ViaCord
- Esperite
- LifeCell
- CCBC
- VCANBIO
- BOYA LIFE
- Beike Biotechnology
- International Medical
- Global Cord Blood Corporation
- Beijing Health-Biotech Group
- ABMD
| Report Attributes |
Report Details |
| Report Title |
Stem Cells Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Stem Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Stem Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Stem Cells Overall Market Size
2.1 Global Stem Cells Market Size: 2021 VS 2028
2.2 Global Stem Cells Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cells Players in Global Market
3.2 Top Global Stem Cells Companies Ranked by Revenue
3.3 Global Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Stem Cells Companies in Global Market, by Revenue in 2021
3.5 Global Companies Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cells Players in Global Market
3.6.1 List of Global Tier 1 Stem Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Stem Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Stem Cells Market Size Markets, 2021 & 2028
4.1.2 Stem Cell Storage
4.1.3 Stem Cell Pharmaceutical and Treatment
4.2 By Type - Global Stem Cells Revenue & Forecasts
4.2.1 By Type - Global Stem Cells Revenue, 2017-2022
4.2.2 By Type - Global Stem Cells Revenue, 2023-2028
4.2.3 By Type - Global Stem Cells Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Stem Cells Market Size, 2021 & 2028
5.1.2 Blood Disease
5.1.3 Cancer
5.1.4 Autoimmune Disease
5.1.5 Others
5.2 By Application - Global Stem Cells Revenue & Forecasts
5.2.1 By Application - Global Stem Cells Revenue, 2017-2022
5.2.2 By Application - Global Stem Cells Revenue, 2023-2028
5.2.3 By Application - Global Stem Cells Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Stem Cells Market Size, 2021 & 2028
6.2 By Region - Global Stem Cells Revenue & Forecasts
6.2.1 By Region - Global Stem Cells Revenue, 2017-2022
6.2.2 By Region - Global Stem Cells Revenue, 2023-2028
6.2.3 By Region - Global Stem Cells Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Stem Cells Revenue, 2017-2028
6.3.2 US Stem Cells Market Size, 2017-2028
6.3.3 Canada Stem Cells Market Size, 2017-2028
6.3.4 Mexico Stem Cells Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Stem Cells Revenue, 2017-2028
6.4.2 Germany Stem Cells Market Size, 2017-2028
6.4.3 France Stem Cells Market Size, 2017-2028
6.4.4 U.K. Stem Cells Market Size, 2017-2028
6.4.5 Italy Stem Cells Market Size, 2017-2028
6.4.6 Russia Stem Cells Market Size, 2017-2028
6.4.7 Nordic Countries Stem Cells Market Size, 2017-2028
6.4.8 Benelux Stem Cells Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Stem Cells Revenue, 2017-2028
6.5.2 China Stem Cells Market Size, 2017-2028
6.5.3 Japan Stem Cells Market Size, 2017-2028
6.5.4 South Korea Stem Cells Market Size, 2017-2028
6.5.5 Southeast Asia Stem Cells Market Size, 2017-2028
6.5.6 India Stem Cells Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Stem Cells Revenue, 2017-2028
6.6.2 Brazil Stem Cells Market Size, 2017-2028
6.6.3 Argentina Stem Cells Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Stem Cells Revenue, 2017-2028
6.7.2 Turkey Stem Cells Market Size, 2017-2028
6.7.3 Israel Stem Cells Market Size, 2017-2028
6.7.4 Saudi Arabia Stem Cells Market Size, 2017-2028
6.7.5 UAE Stem Cells Market Size, 2017-2028
7 Players Profiles
7.1 Osiris Therapeutics
7.1.1 Osiris Therapeutics Corporate Summary
7.1.2 Osiris Therapeutics Business Overview
7.1.3 Osiris Therapeutics Stem Cells Major Product Offerings
7.1.4 Osiris Therapeutics Stem Cells Revenue in Global Market (2017-2022)
7.1.5 Osiris Therapeutics Key News
7.2 NuVasive
7.2.1 NuVasive Corporate Summary
7.2.2 NuVasive Business Overview
7.2.3 NuVasive Stem Cells Major Product Offerings
7.2.4 NuVasive Stem Cells Revenue in Global Market (2017-2022)
7.2.5 NuVasive Key News
7.3 Chiesi Pharmaceuticals
7.3.1 Chiesi Pharmaceuticals Corporate Summary
7.3.2 Chiesi Pharmaceuticals Business Overview
7.3.3 Chiesi Pharmaceuticals Stem Cells Major Product Offerings
7.3.4 Chiesi Pharmaceuticals Stem Cells Revenue in Global Market (2017-2022)
7.3.5 Chiesi Pharmaceuticals Key News
7.4 Medi-post
7.4.1 Medi-post Corporate Summary
7.4.2 Medi-post Business Overview
7.4.3 Medi-post Stem Cells Major Product Offerings
7.4.4 Medi-post Stem Cells Revenue in Global Market (2017-2022)
7.4.5 Medi-post Key News
7.5 JCR Pharmaceutical
7.5.1 JCR Pharmaceutical Corporate Summary
7.5.2 JCR Pharmaceutical Business Overview
7.5.3 JCR Pharmaceutical Stem Cells Major Product Offerings
7.5.4 JCR Pharmaceutical Stem Cells Revenue in Global Market (2017-2022)
7.5.5 JCR Pharmaceutical Key News
7.6 MolMed
7.6.1 MolMed Corporate Summary
7.6.2 MolMed Business Overview
7.6.3 MolMed Stem Cells Major Product Offerings
7.6.4 MolMed Stem Cells Revenue in Global Market (2017-2022)
7.6.5 MolMed Key News
7.7 Pharmicell
7.7.1 Pharmicell Corporate Summary
7.7.2 Pharmicell Business Overview
7.7.3 Pharmicell Stem Cells Major Product Offerings
7.7.4 Pharmicell Stem Cells Revenue in Global Market (2017-2022)
7.7.5 Pharmicell Key News
7.8 Anterogen
7.8.1 Anterogen Corporate Summary
7.8.2 Anterogen Business Overview
7.8.3 Anterogen Stem Cells Major Product Offerings
7.8.4 Anterogen Stem Cells Revenue in Global Market (2017-2022)
7.8.5 Anterogen Key News
7.9 Takeda (TiGenix)
7.9.1 Takeda (TiGenix) Corporate Summary
7.9.2 Takeda (TiGenix) Business Overview
7.9.3 Takeda (TiGenix) Stem Cells Major Product Offerings
7.9.4 Takeda (TiGenix) Stem Cells Revenue in Global Market (2017-2022)
7.9.5 Takeda (TiGenix) Key News
7.10 CBR
7.10.1 CBR Corporate Summary
7.10.2 CBR Business Overview
7.10.3 CBR Stem Cells Major Product Offerings
7.10.4 CBR Stem Cells Revenue in Global Market (2017-2022)
7.10.5 CBR Key News
7.11 ViaCord
7.11.1 ViaCord Corporate Summary
7.11.2 ViaCord Business Overview
7.11.3 ViaCord Stem Cells Major Product Offerings
7.11.4 ViaCord Stem Cells Revenue in Global Market (2017-2022)
7.11.5 ViaCord Key News
7.12 Esperite
7.12.1 Esperite Corporate Summary
7.12.2 Esperite Business Overview
7.12.3 Esperite Stem Cells Major Product Offerings
7.12.4 Esperite Stem Cells Revenue in Global Market (2017-2022)
7.12.5 Esperite Key News
7.13 LifeCell
7.13.1 LifeCell Corporate Summary
7.13.2 LifeCell Business Overview
7.13.3 LifeCell Stem Cells Major Product Offerings
7.13.4 LifeCell Stem Cells Revenue in Global Market (2017-2022)
7.13.5 LifeCell Key News
7.14 CCBC
7.14.1 CCBC Corporate Summary
7.14.2 CCBC Business Overview
7.14.3 CCBC Stem Cells Major Product Offerings
7.14.4 CCBC Stem Cells Revenue in Global Market (2017-2022)
7.14.5 CCBC Key News
7.15 VCANBIO
7.15.1 VCANBIO Corporate Summary
7.15.2 VCANBIO Business Overview
7.15.3 VCANBIO Stem Cells Major Product Offerings
7.15.4 VCANBIO Stem Cells Revenue in Global Market (2017-2022)
7.15.5 VCANBIO Key News
7.16 BOYA LIFE
7.16.1 BOYA LIFE Corporate Summary
7.16.2 BOYA LIFE Business Overview
7.16.3 BOYA LIFE Stem Cells Major Product Offerings
7.16.4 BOYA LIFE Stem Cells Revenue in Global Market (2017-2022)
7.16.5 BOYA LIFE Key News
7.17 Beike Biotechnology
7.17.1 Beike Biotechnology Corporate Summary
7.17.2 Beike Biotechnology Business Overview
7.17.3 Beike Biotechnology Stem Cells Major Product Offerings
7.17.4 Beike Biotechnology Stem Cells Revenue in Global Market (2017-2022)
7.17.5 Beike Biotechnology Key News
7.18 International Medical
7.18.1 International Medical Corporate Summary
7.18.2 International Medical Business Overview
7.18.3 International Medical Stem Cells Major Product Offerings
7.18.4 International Medical Stem Cells Revenue in Global Market (2017-2022)
7.18.5 International Medical Key News
7.19 Global Cord Blood Corporation
7.19.1 Global Cord Blood Corporation Corporate Summary
7.19.2 Global Cord Blood Corporation Business Overview
7.19.3 Global Cord Blood Corporation Stem Cells Major Product Offerings
7.19.4 Global Cord Blood Corporation Stem Cells Revenue in Global Market (2017-2022)
7.19.5 Global Cord Blood Corporation Key News
7.20 Beijing Health-Biotech Group
7.20.1 Beijing Health-Biotech Group Corporate Summary
7.20.2 Beijing Health-Biotech Group Business Overview
7.20.3 Beijing Health-Biotech Group Stem Cells Major Product Offerings
7.20.4 Beijing Health-Biotech Group Stem Cells Revenue in Global Market (2017-2022)
7.20.5 Beijing Health-Biotech Group Key News
7.21 ABMD
7.21.1 ABMD Corporate Summary
7.21.2 ABMD Business Overview
7.21.3 ABMD Stem Cells Major Product Offerings
7.21.4 ABMD Stem Cells Revenue in Global Market (2017-2022)
7.21.5 ABMD Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Stem Cells Market Opportunities & Trends in Global Market
Table 2. Stem Cells Market Drivers in Global Market
Table 3. Stem Cells Market Restraints in Global Market
Table 4. Key Players of Stem Cells in Global Market
Table 5. Top Stem Cells Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Stem Cells Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Stem Cells Revenue Share by Companies, 2017-2022
Table 8. Global Companies Stem Cells Product Type
Table 9. List of Global Tier 1 Stem Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stem Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Stem Cells Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Stem Cells Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Stem Cells Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Stem Cells Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Stem Cells Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Stem Cells Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Stem Cells Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Stem Cells Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Stem Cells Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Stem Cells Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Stem Cells Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Stem Cells Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Stem Cells Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Stem Cells Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Stem Cells Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Stem Cells Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Stem Cells Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Stem Cells Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Stem Cells Revenue, (US$, Mn), 2023-2028
Table 30. Osiris Therapeutics Corporate Summary
Table 31. Osiris Therapeutics Stem Cells Product Offerings
Table 32. Osiris Therapeutics Stem Cells Revenue (US$, Mn), (2017-2022)
Table 33. NuVasive Corporate Summary
Table 34. NuVasive Stem Cells Product Offerings
Table 35. NuVasive Stem Cells Revenue (US$, Mn), (2017-2022)
Table 36. Chiesi Pharmaceuticals Corporate Summary
Table 37. Chiesi Pharmaceuticals Stem Cells Product Offerings
Table 38. Chiesi Pharmaceuticals Stem Cells Revenue (US$, Mn), (2017-2022)
Table 39. Medi-post Corporate Summary
Table 40. Medi-post Stem Cells Product Offerings
Table 41. Medi-post Stem Cells Revenue (US$, Mn), (2017-2022)
Table 42. JCR Pharmaceutical Corporate Summary
Table 43. JCR Pharmaceutical Stem Cells Product Offerings
Table 44. JCR Pharmaceutical Stem Cells Revenue (US$, Mn), (2017-2022)
Table 45. MolMed Corporate Summary
Table 46. MolMed Stem Cells Product Offerings
Table 47. MolMed Stem Cells Revenue (US$, Mn), (2017-2022)
Table 48. Pharmicell Corporate Summary
Table 49. Pharmicell Stem Cells Product Offerings
Table 50. Pharmicell Stem Cells Revenue (US$, Mn), (2017-2022)
Table 51. Anterogen Corporate Summary
Table 52. Anterogen Stem Cells Product Offerings
Table 53. Anterogen Stem Cells Revenue (US$, Mn), (2017-2022)
Table 54. Takeda (TiGenix) Corporate Summary
Table 55. Takeda (TiGenix) Stem Cells Product Offerings
Table 56. Takeda (TiGenix) Stem Cells Revenue (US$, Mn), (2017-2022)
Table 57. CBR Corporate Summary
Table 58. CBR Stem Cells Product Offerings
Table 59. CBR Stem Cells Revenue (US$, Mn), (2017-2022)
Table 60. ViaCord Corporate Summary
Table 61. ViaCord Stem Cells Product Offerings
Table 62. ViaCord Stem Cells Revenue (US$, Mn), (2017-2022)
Table 63. Esperite Corporate Summary
Table 64. Esperite Stem Cells Product Offerings
Table 65. Esperite Stem Cells Revenue (US$, Mn), (2017-2022)
Table 66. LifeCell Corporate Summary
Table 67. LifeCell Stem Cells Product Offerings
Table 68. LifeCell Stem Cells Revenue (US$, Mn), (2017-2022)
Table 69. CCBC Corporate Summary
Table 70. CCBC Stem Cells Product Offerings
Table 71. CCBC Stem Cells Revenue (US$, Mn), (2017-2022)
Table 72. VCANBIO Corporate Summary
Table 73. VCANBIO Stem Cells Product Offerings
Table 74. VCANBIO Stem Cells Revenue (US$, Mn), (2017-2022)
Table 75. BOYA LIFE Corporate Summary
Table 76. BOYA LIFE Stem Cells Product Offerings
Table 77. BOYA LIFE Stem Cells Revenue (US$, Mn), (2017-2022)
Table 78. Beike Biotechnology Corporate Summary
Table 79. Beike Biotechnology Stem Cells Product Offerings
Table 80. Beike Biotechnology Stem Cells Revenue (US$, Mn), (2017-2022)
Table 81. International Medical Corporate Summary
Table 82. International Medical Stem Cells Product Offerings
Table 83. International Medical Stem Cells Revenue (US$, Mn), (2017-2022)
Table 84. Global Cord Blood Corporation Corporate Summary
Table 85. Global Cord Blood Corporation Stem Cells Product Offerings
Table 86. Global Cord Blood Corporation Stem Cells Revenue (US$, Mn), (2017-2022)
Table 87. Beijing Health-Biotech Group Corporate Summary
Table 88. Beijing Health-Biotech Group Stem Cells Product Offerings
Table 89. Beijing Health-Biotech Group Stem Cells Revenue (US$, Mn), (2017-2022)
Table 90. ABMD Corporate Summary
Table 91. ABMD Stem Cells Product Offerings
Table 92. ABMD Stem Cells Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Stem Cells Segment by Type in 2021
Figure 2. Stem Cells Segment by Application in 2021
Figure 3. Global Stem Cells Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Stem Cells Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Stem Cells Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stem Cells Revenue in 2021
Figure 8. By Type - Global Stem Cells Revenue Market Share, 2017-2028
Figure 9. By Application - Global Stem Cells Revenue Market Share, 2017-2028
Figure 10. By Region - Global Stem Cells Revenue Market Share, 2017-2028
Figure 11. By Country - North America Stem Cells Revenue Market Share, 2017-2028
Figure 12. US Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Stem Cells Revenue Market Share, 2017-2028
Figure 16. Germany Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 17. France Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Stem Cells Revenue Market Share, 2017-2028
Figure 24. China Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 28. India Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Stem Cells Revenue Market Share, 2017-2028
Figure 30. Brazil Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Stem Cells Revenue Market Share, 2017-2028
Figure 33. Turkey Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 37. Osiris Therapeutics Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. NuVasive Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Chiesi Pharmaceuticals Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medi-post Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. JCR Pharmaceutical Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MolMed Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pharmicell Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Anterogen Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda (TiGenix) Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CBR Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ViaCord Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Esperite Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. LifeCell Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. CCBC Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. VCANBIO Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. BOYA LIFE Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Beike Biotechnology Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. International Medical Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Global Cord Blood Corporation Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Beijing Health-Biotech Group Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. ABMD Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
